⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DXCM News
DexCom, Inc.
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
businesswire.com
DXCM
Bronstein, Gewirtz & Grossman, LLC Encourages DexCom, Inc. (DXCM) Investors to Inquire about Securities Investigation
accessnewswire.com
DXCM
LexisNexis Recognizes Visionary Companies From 18 Countries as “Top 100 Global Innovators” for 2026
globenewswire.com
IBM
ADI
AMAT
AVGO
CDNS
CSCO
DELL
INTC
LRCX
MRVL
MU
NVDA
QCOM
SNPS
TXN
AMD
LLY
MRNA
BMY
GILD
PFE
JNJ
ABBV
AMGN
BIIB
REGN
VRTX
ADSK
GOOG
MSFT
ORCL
CRM
ADPT
ALGN
BKR
CTAS
DDOG
DXCM
EXPE
FIVN
FTNT
IDXX
ILMN
INTU
ISRG
JD
KDP
LULU
MCHP
MDLZ
MELI
MNST
NFLX
NOW
NTES
OKTA
ON
PANW
PAYX
PDD
PEP
PYPL
ROKU
SBUX
SMCI
SWKS
TEAM
TCOM
TDS
TER
TGT
TTEC
TTWO
TWLO
ULTA
VRSK
WDC
WEC
XRAY
ZBRA
ZM
ASML
KLAC
NXPI
AMZN
AAPL
GOOGL
META
TSLA
Z
KHC
CL
PG
COST
WMT
Form 8-K
sec.gov
DXCM
Form 8-K
sec.gov
DXCM
Dexcom Appoints Rick Osterloh to Board of Directors
businesswire.com
DXCM
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
prnewswire.com
DXCM
Dexcom Announces Upcoming Conference Presentation
businesswire.com
DXCM
Study Confirms Safety of Using Theranica's Nerivio® REN Wearable for Treatment of Migraine Simultaneously with Contemporary Continuous Glucose Monitoring (CGM) Devices
prnewswire.com
ABT
DXCM
Nuclear Medicine Market Growth Forecast at 12.5% CAGR to 2031 as Diagnostic Imaging and Targeted Radiopharmaceuticals Gain Momentum, Says 2026 Mordor Intelligence Report
globenewswire.com
ABT
BSX
BDX
MDT
DXCM